| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1651-2227.1988.TB10718.X |
| P698 | PubMed publication ID | 2455956 |
| P2093 | author name string | Vesikari T | |
| Cantell K | |||
| Nuutila A | |||
| P2860 | cites work | Central nervous system toxicity of interferon | Q41507160 |
| P433 | issue | 4 | |
| P921 | main subject | larynx | Q9637 |
| P304 | page(s) | 619-622 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Acta Paediatrica Scandinavica | Q27708772 |
| P1476 | title | Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma | |
| P478 | volume | 77 |
| Q36589103 | Central Nervous System Toxicity of Biological Response Modifiers |
| Q40390091 | Clinical toxicity of the interferons. |
| Q43860459 | Do white cells matter in white-matter damage? |
| Q71735473 | Growth retardation as a long-term side-effect of alpha-interferon therapy |
| Q41109626 | Hepatic vascular anomalies in infancy: a twenty-seven-year experience |
| Q30652944 | Interferons and cerebral palsy |
| Q35286757 | Is some white matter damage in preterm neonates induced by a human pestivirus? |
| Q69587156 | Juvenile chronic myeloid leukaemia and alpha-interferon |
| Q71133664 | MR imaging of hepatic hemangiomas of infancy and changes seen with interferon alpha-2a treatment |
| Q35105059 | Neurologic complications of cancer therapy |
| Q73110578 | Neurologic toxicity associated with interferon alfa treatment of capillary hemangioma |
| Q77647350 | Neurotoxicity of interferon alfa in children treated for hemangiomas |
| Q79118966 | Omission of interferon alpha information in Nelson at al.'s article |
| Q35651949 | Sirolimus for the treatment of children with various complicated vascular anomalies. |
| Q74579871 | Spastic diplegia and interferon |
| Q48490321 | Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy |
| Q30757070 | Subglottic haemangioma: controversies in management |
| Q47771603 | The effect of low-dose interferon treatment on visual evoked potentials |
| Q60316099 | Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis |
| Q73243921 | Toxicity profile of interferon alfa-2b in children: A prospective evaluation |
| Q53916510 | [Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants]. |
Search more.